SLR Pharma

Hyderabad, India
API manufacturing and pharmaceutical intermediates services in India.

About SLR Pharma

SLR Pharma is a Healthcare company based in Hyderabad (India). API manufacturing and pharmaceutical intermediates services in India. The company has 27 employees. Its Indian entity Slr Pharma Private Limited reported revenue of β‚Ή39.77 Cr. SLR Pharma offers products and services including Tramadol Hydrochloride API and Setraline Hydrochloride API. Its focus areas include Pharmaceuticals, API Manufacturing, Active Pharmaceutical Ingredients and Chemicals.

Company details

SLR Pharma is recognized as an integrated manufacturer of Active Pharmaceutical Ingredients and intermediates, based in Tirupati, Andhra Pradesh, India. The company is managed by industry professionals with over 25 years of experience, leading to its growth and an impressive turnover of 20 crores in its second year. Production facilities include two for intermediates and one WHO-GMP certified for finished products. High-quality manufacturing is supported by technical expertise and international certifications, enabling the supply of APIs used in essential drugs by multiple global brands. Sustainability and quality policies are emphasized in operations, with facilities located in key Indian regions to serve clients effectively.

  • Headquarters Hyderabad, India
  • Employees 27
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website slrpharma.com
  • Legal Name Slr Pharma Private Limited
  • Date of Incorporation 20 Sep, 2004
  • Jurisdiction Hyderabad, Telangana, India
Key Metrics
  • Annual Revenue
    ₹39.77 Cr

    FY 2024 · -25% YoY

  • Net Profit
    ₹1.42 Cr

    FY 2024 · 4% margin

  • EBITDA
    ₹3.19 Cr

    FY 2024 · 8% margin

  • Employee Count
    27

Products & Services of SLR Pharma

SLR Pharma offers a comprehensive portfolio of products and services, including Tramadol Hydrochloride API and Setraline Hydrochloride API.

Tramadol Hydrochloride API
Active Pharmaceutical Ingredients

Tramadol Hydrochloride API is manufactured for use in essential drugs, with production processes supported by experienced professionals and certified facilities

Setraline Hydrochloride API
Active Pharmaceutical Ingredients

Setraline Hydrochloride API is produced as part of the company's range of APIs, contributing to drugs used by various brands worldwide

Board of directors of Slr Pharma Private Limited (SLR Pharma)

Slr Pharma Private Limited is the primary company behind SLR Pharma. The board of Slr Pharma Private Limited currently have 3 directors; the longest-serving is Ramireddy Suryanarayana Reddy, appointed in 2007. 5 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Ramireddy Suryanarayana Reddy
DIN 03495299
Director19 Feb 200719 yrs 8 moSlr Pharma Private Limited
Lakshmi Ramireddy
DIN 06854638
Director12 Dec 201312 yrs 11 moSlr Pharma Private Limited
Sathya Pruthvirajreddy Rami Reddy
DIN 07303676
Director18 Oct 20215 yrs 1 moSlr Pharma Private Limited

Financials of SLR Pharma

Figures of Slr Pharma Private Limited, the primary company behind SLR Pharma, for FY 2024. Revenue was ₹39.77 Cr (-25% year on year). Net profit was ₹1.42 Cr (4% margin). EBITDA was ₹3.19 Cr (8% margin). Revenue has grown at a compounded annual rate of +9% over three years and +16% over five years.

  • ₹39.77 CrRevenue · FY 2024 · -25% YoY
  • ₹1.42 CrNet profit · 4% margin
  • ₹3.19 CrEBITDA · 8% margin
  • ₹9.48 CrPaid-up capital
  • 27Employees (provident fund records)
  • +9%Revenue CAGR, 3 years
  • +16%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Slr Pharma Private Limited are on its company page.

Premium access

Detailed financial statements for SLR Pharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about SLR Pharma

SLR Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

SLR Pharma has 27 employees.

The primary company behind SLR Pharma, Slr Pharma Private Limited, reported revenue of β‚Ή39.77 Cr for FY 2024, down 25% year on year.

SLR Pharma is recognized as an integrated manufacturer of Active Pharmaceutical Ingredients and intermediates, based in Tirupati, Andhra Pradesh, India. The company is managed by industry professionals with over 25 years of experience, leading to its growth and an impressive turnover of 20 crores in its second year. Production facilities include two for intermediates and one WHO-GMP certified for finished products. High-quality manufacturing is supported by technical expertise and international certifications, enabling the supply of APIs used in essential drugs by multiple global brands. Sustainability and quality policies are emphasized in operations, with facilities located in key Indian regions to serve clients effectively.

SLR Pharma offers Tramadol Hydrochloride API and Setraline Hydrochloride API.

SLR Pharma operates through Slr Pharma Private Limited.

The legal entities of SLR Pharma currently have 3 directors, including Ramireddy Suryanarayana Reddy, Lakshmi Ramireddy, Sathya Pruthvirajreddy Rami Reddy.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available